Timothy P. Walbert - 24 Feb 2025 Form 3/A - Amendment Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Director
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
24 Feb 2025
Net transactions value
$0
Form type
3/A - Amendment
Filing time
07 Mar 2025, 16:03:55 UTC
Date Of Original Report
26 Feb 2025
Previous filing
21 Jun 2024
Next filing
22 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BMRN Common Stock 416 24 Feb 2025 Shares held by Prairie Capital Ventures LLC F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were omitted from the reporting person's original Form 3 and were omitted from the Form 4 filed by the reporting person after his original Form 3 was filed.
F2 Prairie Capital Ventures LLC is an investment vehicle controlled by the reporting person.